Becton, Dickinson and Company BDX
- Market cap
- $48.8B
- P/E
- 55.4×
Follow BDX
Becton, Dickinson and Company (BDX) Price to free cash flow
As of 25 September 2026, Becton, Dickinson and Company (BDX) trades at a price to free cash flow of 15.8×. Over the past ten years it has ranged from 11.3× (June 2026) to 54.9× (April 2022); the current reading is higher than 12% of that period. That is below the Medical Instruments & Supplies industry median of 25.7× and below the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 15.9× | (9.97%) |
| FY2024 | 17.6× | (35.77%) |
| FY2023 | 27.4× | (17.74%) |
| FY2022 | 33.3× | 79.17% |
| FY2021 | 18.6× | (18.99%) |
| FY2020 | 23.0× | 4.04% |
| FY2019 | 22.1× | (17.01%) |
| FY2018 | 26.6× | 47.08% |
| FY2017 | 18.1× | 15.07% |
| FY2016 | 15.7× | (0.42%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 13.0× | 2.83% |
| Mar 2026 | 12.6× | (23.76%) |
| Dec 2025 | 16.6× | 4.46% |
| Sep 2025 | 15.9× | (15.33%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SOLV Solventum Corporation compare | n/m |
| MDLN Medline Inc. compare | 12.9× |
| BAX Baxter International Inc. compare | 14.8× |
| BDX Becton, Dickinson and Company | 15.8× |
| ALC Alcon compare | 19.7× |
| RMD ResMed Inc. compare | 19.9× |
| ISRG Intuitive Surgical, Inc. compare | 43.9× |
| WST West Pharmaceutical Services, Inc. compare | 60.6× |
| RGEN Repligen Corporation compare | 175× |
| Medical Instruments & Supplies industry median | 25.7× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on BDX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement